{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:35:40Z","timestamp":1790674540016,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.parkreldis.2022.05.003","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T03:11:54Z","timestamp":1652411514000},"page":"23-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Decreased CSF oxytocin relates to measures of social cognitive impairment in Huntington's disease patients"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9026-1073","authenticated-orcid":false,"given":"Marie N.N.","family":"Hellem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0264-7636","authenticated-orcid":false,"given":"Rachel Y.","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Tonetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tua","family":"Vinther-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca K.","family":"Hendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida U.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troels T.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena E.","family":"Hjermind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmus","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esben","family":"Budtz-J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5sa","family":"Peters\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0453-5582","authenticated-orcid":false,"given":"J\u00f8rgen E.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1110","key":"10.1016\/j.parkreldis.2022.05.003_bib1","first-page":"204","article-title":"Huntington disease: natural history, biomarkers and prospects for therapeutics","volume":"10","author":"Ross","year":"2014","journal-title":"Nat. Publ. Gr."},{"issue":"2","key":"10.1016\/j.parkreldis.2022.05.003_bib2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/01.wnn.0000152205.79033.73","article-title":"White matter volume and cognitive dysfunction in early Huntington's disease","volume":"18","author":"Beglinger","year":"2005","journal-title":"Cognit. Behav. Neurol."},{"key":"10.1016\/j.parkreldis.2022.05.003_bib3","first-page":"5","volume":"vol. 1","author":"Peters\u00e9n","year":"2012"},{"key":"10.1016\/j.parkreldis.2022.05.003_bib4","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00401-010-0742-6","article-title":"Changes in key hypothalamic neuropeptide populations in Huntington disease revealed by neuropathological analyses","volume":"120","author":"Gabery","year":"2010","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.parkreldis.2022.05.003_bib5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.31887\/DCNS.2015.17.4\/pkirsch","article-title":"Oxytocin in the socioemotional brain: implications for psychiatric disorders","volume":"17","author":"Kirsch","year":"2015","journal-title":"Dialogues Clin. Neurosci."},{"issue":"4","key":"10.1016\/j.parkreldis.2022.05.003_bib6","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3233\/JHD-190372","article-title":"The role of hypothalamic pathology for non-motor features of Huntington's disease","volume":"8","author":"Cheong","year":"2019","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.parkreldis.2022.05.003_bib7","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/nan.12236","article-title":"Selective loss of oxytocin and vasopressin in the hypothalamus in early Huntington disease: a case study","volume":"41","author":"Gabery","year":"2015","journal-title":"Neurobiol. Appl."},{"issue":"4","key":"10.1016\/j.parkreldis.2022.05.003_bib8","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.yfrne.2009.05.005","article-title":"Oxytocin, vasopressin, and human social behavior","volume":"30","author":"Heinrichs","year":"2009","journal-title":"Front. Neuroendocrinol."},{"issue":"2","key":"10.1016\/j.parkreldis.2022.05.003_bib9","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1212\/WNL.54.2.452","article-title":"Rate of functional decline in Huntington's disease","volume":"54","author":"Marder","year":"2000","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.parkreldis.2022.05.003_bib10","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41562-020-0878-x","article-title":"A registered replication study on oxytocin and trust","volume":"4","author":"Declerck","year":"2020","journal-title":"Nat. Human Behav."},{"issue":"9","key":"10.1016\/j.parkreldis.2022.05.003_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci8090161","article-title":"Social cognition and oxytocin in Huntington's disease: new insights","volume":"8","author":"Unti","year":"2018","journal-title":"Brain Sci."},{"key":"10.1016\/j.parkreldis.2022.05.003_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2017.09.023","article-title":"Oxytocin selectively modulates brain processing of disgust in Huntington's disease gene carriers","volume":"81","author":"Labuschagne","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.parkreldis.2022.05.003_bib13","first-page":"1","article-title":"The relationship between plasma oxytocin and executive functioning in Huntington's disease: a pilot study","author":"Fisher","year":"2021","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.parkreldis.2022.05.003_bib14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbr.2015.10.001","article-title":"Social cognition in Huntington's disease: a meta-analysis","volume":"297","author":"Bora","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.parkreldis.2022.05.003_bib15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13023-014-0114-8","article-title":"A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington's disease","volume":"9","author":"Vinther-Jensen","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"issue":"1","key":"10.1016\/j.parkreldis.2022.05.003_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-021-01967-2","article-title":"Endophenotypical drift in Huntington's disease: a 5-year follow-up study","volume":"16","author":"Hellem","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"issue":"9","key":"10.1016\/j.parkreldis.2022.05.003_bib17","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1474-4422(09)70170-X","article-title":"Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data","volume":"8","author":"Tabrizi","year":"2009","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.parkreldis.2022.05.003_bib18","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.nbd.2014.12.009","article-title":"Longitudinal change in white matter microstructure in Huntington's disease: the IMAGE-HD study","volume":"74","author":"Poudel","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.parkreldis.2022.05.003_bib19","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ana.410410521","article-title":"CAG repeat number governs the development rate of pathology in Huntington's disease","volume":"41","author":"Penney","year":"1997","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.parkreldis.2022.05.003_bib20","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/ana.25647","article-title":"Early intrathecal T Helper 17.1 cell activity in huntington disease","volume":"87","author":"von Essen","year":"2020","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.parkreldis.2022.05.003_bib21","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000287","article-title":"Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease","volume":"3","author":"Vinther-Jensen","year":"2016","journal-title":"Neurol - Neuroimmunol Neuroinflammation"},{"issue":"11","key":"10.1016\/j.parkreldis.2022.05.003_bib22","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.parkreldis.2014.08.011","article-title":"YKL-40 in cerebrospinal fluid in Huntington's disease - a role in pathology or a nonspecific response to inflammation?","volume":"20","author":"Vinther-Jensen","year":"2014","journal-title":"Park. Relat. Disord."},{"issue":"4","key":"10.1016\/j.parkreldis.2022.05.003_bib23","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"issue":"3","key":"10.1016\/j.parkreldis.2022.05.003_bib24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00001199-200305000-00001","article-title":"A new clinical tool for assessing social perception after traumatic brain injury","volume":"18","author":"McDonald","year":"2003","journal-title":"J. Head Trauma Rehabil."},{"key":"10.1016\/j.parkreldis.2022.05.003_bib25","first-page":"1","article-title":"Normative data for Emotion Hexagon test and frequency of impairment in behavioral variant frontotemporal dementia, Alzheimer's disease and Huntington's disease","author":"Vogel","year":"2020","journal-title":"Appl. Neuropsychol."},{"issue":"6","key":"10.1016\/j.parkreldis.2022.05.003_bib26","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.biopsych.2006.07.015","article-title":"Oxytocin improves \u201cMind-reading\u201d in humans","volume":"61","author":"Domes","year":"2007","journal-title":"Biol. Psychiatr."},{"issue":"5","key":"10.1016\/j.parkreldis.2022.05.003_bib27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/HRP.0b013e3182a75b7d","article-title":"The role of oxytocin in psychiatric disorders: a review of biological and therapeutic research findings","volume":"21","author":"Cochran","year":"2013","journal-title":"Harv. Rev. Psychiatr."},{"issue":"3","key":"10.1016\/j.parkreldis.2022.05.003_bib28","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s12031-011-9550-2","article-title":"New potential therapeutic approaches in frontotemporal dementia: oxytocin, vasopressin, and social cognition","volume":"45","author":"Finger","year":"2011","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.parkreldis.2022.05.003_bib29","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.neubiorev.2016.11.020","article-title":"Beyond emotion recognition deficits: a theory guided analysis of emotion processing in Huntington's disease","volume":"73","author":"Kordsachia","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.parkreldis.2022.05.003_bib30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1037\/neu0000224","article-title":"Do i misconstrue? Sarcasm detection, emotion recognition, and theory of mind in huntington disease","volume":"30","author":"Larsen","year":"2016","journal-title":"Neuropsychology"},{"issue":"3","key":"10.1016\/j.parkreldis.2022.05.003_bib31","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.yhbeh.2012.01.002","article-title":"A critical review of the influence of oxytocin nasal spray on social cognition in humans: evidence and future directions","volume":"61","author":"Graustella","year":"2012","journal-title":"Horm. Behav."},{"issue":"1","key":"10.1016\/j.parkreldis.2022.05.003_bib32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1742-9544.2011.00054.x","article-title":"New frontiers in neuropsychological assessment: assessing social perception using a standardised instrument, the awareness of social inference test","volume":"47","author":"McDonald","year":"2012","journal-title":"Aust. Psychol."},{"issue":"1","key":"10.1016\/j.parkreldis.2022.05.003_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/scan\/nsv093","article-title":"Theory of mind and empathy in preclinical and clinical Huntington's disease","volume":"11","author":"Adjeroud","year":"2015","journal-title":"Soc. Cognit. Affect Neurosci."},{"issue":"3","key":"10.1016\/j.parkreldis.2022.05.003_bib34","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.yhbeh.2011.12.003","article-title":"Modulating social behavior with oxytocin: How does it work? What does it mean?","volume":"61","author":"Churchland","year":"2012","journal-title":"Horm. Behav."},{"key":"10.1016\/j.parkreldis.2022.05.003_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2016.04.010","article-title":"Low dose intranasal oxytocin delivered with Breath Powered device dampens amygdala response to emotional stimuli: a peripheral effect-controlled within-subjects randomized dose-response fMRI trial","volume":"69","author":"Quintana","year":"2016","journal-title":"Psychoneuroendocrinology"},{"issue":"2\u20133","key":"10.1016\/j.parkreldis.2022.05.003_bib36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1054\/npep.2002.0909","article-title":"The social deficits of the oxytocin knockout mouse","volume":"36","author":"Winslow","year":"2002","journal-title":"Neuropeptides"},{"issue":"19","key":"10.1016\/j.parkreldis.2022.05.003_bib37","doi-asserted-by":"crossref","first-page":"e2635","DOI":"10.1212\/WNL.0000000000010933","article-title":"Neural effects of oxytocin and mimicry in frontotemporal dementia: a randomized crossover study","volume":"95","author":"Oliver","year":"2020","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.parkreldis.2022.05.003_bib38","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/brain\/awr171","article-title":"The effects of oxytocin on social cognition and behaviour in frontotemporal dementia","volume":"134","author":"Jesso","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2022.05.003_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpsyt.2019.00930","article-title":"Oxytocin as treatment for social cognition, not there yet","volume":"10","author":"Erdozain","year":"2020","journal-title":"Front. Psychiatr."},{"issue":"1","key":"10.1016\/j.parkreldis.2022.05.003_bib40","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13195-018-0427-2","article-title":"Adaptive crossover designs for assessment of symptomatic treatments targeting behaviour in neurodegenerative disease: a phase 2 clinical trial of intranasal oxytocin for frontotemporal dementia (FOXY)","volume":"10","author":"Finger","year":"2018","journal-title":"Alzheimer's Res. Ther."},{"issue":"2","key":"10.1016\/j.parkreldis.2022.05.003_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0117593","article-title":"Volumetric analysis of the hypothalamus in huntington disease using 3T MRI: the IMAGE-HD study","volume":"10","author":"Gabery","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.parkreldis.2022.05.003_bib42","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s11682-014-9333-9","article-title":"Oxytocin and vasopressin effects on the neural response to social cooperation are modulated by sex in humans","volume":"9","author":"Feng","year":"2015","journal-title":"Brain Imaging Behav"},{"issue":"5","key":"10.1016\/j.parkreldis.2022.05.003_bib43","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.psyneuen.2012.08.011","article-title":"Plasma oxytocin distributions in a large cohort of women and men and their gender-specific associations with anxiety","volume":"38","author":"Weisman","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.parkreldis.2022.05.003_bib44","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.brainres.2013.10.052","article-title":"Oxytocin and vasopressin support distinct configurations of social synchrony","volume":"1580","author":"Apter-Levi","year":"2014","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.parkreldis.2022.05.003_bib45","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2174\/1745017901915010058","article-title":"Sex-related differences in plasma oxytocin levels in humans","volume":"15","author":"Marazziti","year":"2019","journal-title":"Clin. Pract. Epidemiol. Ment. Health"},{"issue":"5","key":"10.1016\/j.parkreldis.2022.05.003_bib46","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.psyneuen.2012.08.011","article-title":"Plasma oxytocin distributions in a large cohort of women and men and their gender-specific associations with anxiety","volume":"38","author":"Weisman","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.parkreldis.2022.05.003_bib47","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neubiorev.2017.04.017","article-title":"The correlation between central and peripheral oxytocin concentrations: a systematic review and meta-analysis","volume":"78","author":"Valstad","year":"2017","journal-title":"Neurosci. Biobehav. Rev."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802022001225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802022001225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:25:31Z","timestamp":1761179131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802022001225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":47,"alternative-id":["S1353802022001225"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2022.05.003","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decreased CSF oxytocin relates to measures of social cognitive impairment in Huntington's disease patients","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2022.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}